부산대학교 도서관

Sockel K; Stölzel F; Hönl F; Baldauf H; Röllig C; Wermke M; von Bonin M; Teipel R; Link-Rachner C; Brandt K; Kroschinsky F; Hänel M; Morgner A; Klesse C; Ehninger G; Platzbecker U; Bornhäuser M; Schetelig J; Middeke JM

Cancer Management and Research, Vol Volume 14, Pp 547-559 (2022)

Röllig C; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.; Ruhnke L; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Fransecky L; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Heydrich BN; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Hanoun M; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Noppeney R; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Schäfer-Eckart K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany.; Wendelin K; Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany.; Mikesch JH; Department of Medicine A, University Hospital Münster, Münster, Germany.; Middeke JM; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Reimann M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Fiebig F; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Zukunft S; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Wermke M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; Serve H; Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany.; Platzbecker U; Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.; Müller-Tidow C; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.; Baldus CD; Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Bornhäuser M; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Dresden, Germany.; National Center for Tumor Diseases Dresden, Dresden, Germany.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Illini O; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.; Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Christopoulos P; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Thoraxklinik and Translational Lung Research Center (TLRC), member of the German Center for Lung Research (DZL), Heidelberg University Hospital, 69126 Heidelberg, Germany.; Duruisseaux M; Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, 69002 Lyon, France.; Oncopharmacology Laboratory, Cancer Research Center of Lyon, Unité Mixte de Recherche (UMR), Institut National de la Santé et de la Recherche Médicale (INSERM), 1052 Centre National de la Recherche Scientifique (CNRS), 5286 Lyon, France.; Université Claude Bernard, Université de Lyon, 69622 Villeurbanne cedex, France.; Vikström A; Department of Pulmonary Medicine, University Hospital Linköping, 58185 Linköping, Sweden.; Peled N; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Demedts I; Department of Pulmonary Diseases, AZ Delta, Deltalaan 1, 8800 Roeselare, Belgium.; Dudnik E; Head, Thoracic Oncology Service, Assuta Medical Centers, Tel-Aviv 6329302, Israel.; Faculty of Health Sciences, Ben-Gurion Unversity of the Negev, Be'er Sheva 84105, Israel.; Eisert A; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.; Hashemi SMS; Department of Pulmonary Medicine, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, 1081 Amsterdam, The Netherlands.; Janzic U; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.; Medical Oncology Unit, University Clinic Golnik, 4204 Golnik, Slovenia.; Kian W; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Institute of Oncology, Assuta Ashdod University Hospital, Ashdod 7747629, Israel.; Mohorcic K; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.; Mohammed S; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent TN24QJ, UK.; Silvoniemi M; Department of Pulmonary Diseases, Turku University Hospital, University of Turku, 20014 Turku, Finland.; Rothschild SI; Center for Oncology & Hematology and Comprehensive Cancer Center, Cantonal Hospital Baden, 5404 Baden, Switzerland.; Schulz C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Internal Medicine II, University Hospital, 93053 Regensburg, Germany.; Wesseler C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Pneumology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, 21075 Hamburg, Germany.; Addeo A; Oncology Department, University Hospital Geneva, 1205 Geneva, Switzerland.; Armster K; Department of Pneumology, Universitätsklinikum Krems, 3500 Krems an der Donau, Austria.; Itchins M; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.; Ivanović M; Department of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.; Kauffmann-Guerrero D; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Thoracic Oncology Center Munich, University Hospital, University of Munich (LMU), 81377 Munich, Germany.; Koivunen J; Department of Oncology and Radiotherapy, Oulu University Hospital, 90014 Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, 90014 Oulu, Finland.; Medical Research Center Oulu, 90014 Oulu, Finland.; Kuon J; Department Thoracic Oncology, SLK Fachklinik Löwenstein, 74245 Löwenstein, Germany.; Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.; Piet B; Department of Respiratory Medicine, Radboudumc, 6225 GA Nijmegen, The Netherlands.; Sebastian M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Medicine, Hematology/Oncology, University Hospital, University of Frankfurt, 60596 Frankfurt am Main, Germany.; Velthaus-Rusik JL; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Wannesson L; Istituto Oncologico della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Wiesweg M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, 45147 Essen, Germany.; Wurm R; Division of Pulmonology, Department of Internal Medicine, LKH-Universitätsklinikum, Medical University of Graz, 8036 Graz, Austria.; Albers-Leischner C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Aust DE; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; Janning M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.; Fabikan H; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.; Herold S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; Klimova A; Core Unit for Data Management and Analytics, National Center for Tumor Diseases, 01307 Dresden, Germany.; Loges S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.; Sharapova Y; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.; Schütz M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; Weinlinger C; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.; Valipour A; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.; Overbeck TR; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen University, 37075 Göttingen, Germany.; Griesinger F; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Oncology, Pius University Hospital, University Medicine Oldenburg, 26121 Oldenburg, Germany.; Jakopovic M; Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.; Hochmair MJ; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.; Wermke M; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Brunner AM; Massachusetts General Hospital, Boston, Massachusetts, USA.; Esteve J; Hospital Clínic, Barcelona, Spain.; Porkka K; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Knapper S; School of Medicine, Cardiff University, Cardiff, UK.; Traer E; Oregon Health & Science University, Portland, Oregon, USA.; Scholl S; University Hospital Jena, Jena, Germany.; Garcia-Manero G; MD Anderson Cancer Center, Houston, Texas, USA.; Vey N; Institut Paoli-Calmettes, Marseille, France.; Wermke M; TU Dresden, NCT/UCC Early Clinical Trial Unit, Dresden, Germany.; Janssen JJWM; Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Narayan R; Massachusetts General Hospital, Boston, Massachusetts, USA.; Fleming S; The Alfred Hospital, Melbourne, Victoria, Australia.; Loo S; The Alfred Hospital, Melbourne, Victoria, Australia.; Tovar N; Hospital Clínic, Barcelona, Spain.; Kontro M; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Ottmann OG; School of Medicine, Cardiff University, Cardiff, UK.; Naidu P; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Sun H; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Han M; Cure Ventures, Boston, Massachusetts, USA.; White R; Novartis Ireland Limited, Dublin, Ireland.; Zhang N; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.; Mohammed A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Sabatos-Peyton CA; Larkspur Biosciences, Cambridge, Massachusetts, USA.; Steensma DP; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.; Rinne ML; Blueprint Medicines, Cambridge, Massachusetts, USA.; Borate UM; Oregon Health & Science University, Portland, Oregon, USA.; Wei AH; The Peter MacCallum Cancer Centre and Royal Melbourne Hospital Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Jiang G; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Neuber B; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Hückelhoven-Krauss A; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Höpken UE; Department of Translational Tumor Immunology, Max-Delbrück Center for Molecular Medicine (MDC), 13125 Berlin, Germany.; Ding Y; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Sedloev D; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Wang L; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Reichman A; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Eberhardt F; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Wermke M; Early Clinical Trial Unit (ECTU), Medical Clinic and Poliklinik I, Carl Gustav Carus University, 01307 Dresden, Germany.; Rehm A; Department of Translational Tumor Immunology, Max-Delbrück Center for Molecular Medicine (MDC), 13125 Berlin, Germany.; Müller-Tidow C; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Schmitt A; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.; Schmitt M; Department of Internal Medicine V, University Clinic Heidelberg, 69120 Heidelberg, Germany.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Kästner A; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany.; Kron A; National Network Genomic Medicine Lung Cancer, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.; van den Berg N; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany.; Moon K; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany.; Scheffler M; National Network Genomic Medicine Lung Cancer, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.; Schillinger G; Federal Association of the AOK, Berlin, Germany.; Pelusi N; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, University Hospital Bonn, Bonn, Germany.; Hartmann N; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.; Rieke DT; National Network Genomic Medicine Lung Cancer, Germany.; Charité Comprehensive Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany.; Stephan-Falkenau S; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Helios Klinikum Emil von Behring, Berlin, Germany.; Schuler M; National Network Genomic Medicine Lung Cancer, Germany.; West German Cancer Center, University Hospital Essen, Essen, Germany.; Wermke M; National Network Genomic Medicine Lung Cancer, Germany.; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus and Medical Faculty of the TU Dresden, Dresden, Germany.; Weichert W; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Technical University of Munich (TUM), Munich, Germany.; Klauschen F; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Germany.; Haller F; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.; Hummel HD; National Network Genomic Medicine Lung Cancer, Germany.; Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken and Bavarian Cancer Research Center (BZKF), University Hospital Würzburg, Würzburg, Germany.; Sebastian M; National Network Genomic Medicine Lung Cancer, Germany.; Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany.; Gattenlöhner S; National Network Genomic Medicine Lung Cancer, Germany.; Department of Pathology, University Hospital Giessen and Marburg, Giessen, Germany.; Bokemeyer C; National Network Genomic Medicine Lung Cancer, Germany.; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Esposito I; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany.; Jakobs F; National Network Genomic Medicine Lung Cancer, Germany.; Department of Hematology and Stem Cell Transplantation, Faculty of Medicine and University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; von Kalle C; National Network Genomic Medicine Lung Cancer, Germany.; Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.; Büttner R; National Network Genomic Medicine Lung Cancer, Germany.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University of Cologne, Cologne, Germany.; Wolf J; National Network Genomic Medicine Lung Cancer, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne, University Hospital of Cologne, Cologne, Germany.; Hoffmann W; Institute for Community Medicine, Section Epidemiology of Health Care and Community Health, University Medicine Greifswald, Greifswald, Germany.

Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE

Saalfeld FC; Aust DE; Wermke M

Publisher: G. Thieme Country of Publication: Germany NLM ID: 0006723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-4413 (Electronic) Linking ISSN: 00120472 NLM ISO Abbreviation: Dtsch Med Wochenschr Subsets: MEDLINE

Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Cohen YC; Department of Hematology, Tel-Aviv Sourasky (Ichilov) Medical Center, Tel Aviv University, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; Aardalen K; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Oka A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Spencer A; Department of Malignant Haematology, The Alfred Hospital, Melbourne, VIC, Australia.; Wermke M; NCT/UCC Early Clinical Trial Unit, Universitätsklinikum Carl Gustav Carus an der Technische Universität, Dresden, Germany.; Souza AD; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Cafro AM; Department of Hematology, Niguarda Hospital, Niguarda, Milan, Italy.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.; Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.; Henson K; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Trabucco G; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Carrion A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Bender FC; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Juif PE; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Fessehatsion A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Fan L; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Stonehouse JP; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Blankenship JW; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Granda B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; De Vita S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. serena.de_vita@novartis.com.; Lu H; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. haihui.lu@novartis.com.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

de Braud F; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Medical Oncology and Hematology Department, Istituto Nazionale dei Tumori, Milan, Italy.; Dooms C; University Hospitals Leuven, Leuven, Belgium.; Heist RS; Cancer Center, Massachusetts General Hospital, Boston, MA.; Lebbe C; Department of Dermato-Oncology and CIC, AP-HP Hôpital Saint Louis, Université Paris Cité, Inserm U976, Paris, France.; Wermke M; NCT/UCC Early Clinical Trial Unit, Technical University Dresden, Dresden, Germany.; Gazzah A; Department of Medical Oncology, Thoracic Cancer Group, Gustave Roussy Cancer Institute, Villejuif, France.; Schadendorf D; Department of Dermatology, University Hospital Essen & German Cancer Consortium, Partner Site Essen, Essen, Germany.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Wolf J; Center for Integrated Oncology, Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.; Ascierto PA; Melanoma and Cancer Immunotherapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Gil-Bazo I; Program in Solid Tumors, Cima-University of Navarra, Pamplona, Spain.; Navarra's Health Research Institute (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Kato S; University of California San Diego, San Diego, CA.; Wolodarski M; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.; McKean M; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, TN.; Muñoz Couselo E; Department of Medical Oncology, Melanoma and Other Skin Cancers Unit, Vall d'Hebron Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Sebastian M; Department of Hematology and Medical Oncology, University Hospital Frankfurt, Frankfurt, Germany.; Santoro A; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.; Cooke V; Novartis Institutes for BioMedical Research, Cambridge, MA.; Manganelli L; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Wan K; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gaur A; Novartis Healthcare Private Limited, Hyderabad, India.; Kim J; Novartis Institutes for BioMedical Research, Cambridge, MA.; Caponigro G; Novartis Institutes for BioMedical Research, Cambridge, MA.; Couillebault XM; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Evans H; Novartis Pharma AG, Basel, Switzerland.; Campbell CD; Novartis Institutes for BioMedical Research, Cambridge, MA.; Basu S; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Moschetta M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Daud A; Department of Medicine, University of California San Francisco, San Francisco, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Chesney J; Department of Medicine, University of Louisville, Louisville, Kentucky, USA.; Lewis KD; Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.; Kluger H; Medical Oncology, Hematology & Oncology, Melanoma and Onco-Dermatology, Genitourinary Oncology, Yale New Haven Health Smilow Cancer Hospital, New Haven, Connecticut, USA.; Hamid O; Hematology Oncology, The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, California, USA.; Whitman E; Atlantic Health System Cancer Care, Morristown, New Jersey, USA.; Thomas S; Hematology and Oncology, Orlando Health Cancer Institute, Orlando, Florida, USA.; Wermke M; Technische Universität Dresden - NCT/UCC Early Clinical Trial Unit, Dresden, Sachsen, Germany.; Cusnir M; Division of Hematology & Oncology, Mount Sinai Medical Center, Miami Beach, Florida, USA.; Domingo-Musibay E; Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.; Phan GQ; Surgery, Virginia Commonwealth University, Massey Cancer Center, Richmond, Virginia, USA.; Kirkwood JM; Medicine, Dermatology and Translational Science, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Hassel JC; Skin Cancer Center, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany.; Orloff M; Thomas Jefferson University Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, USA.; Larkin J; The Royal Marsden NHS Foundation Trust, London, UK.; Weber J; Department of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA.; Furness AJS; The Royal Marsden NHS Foundation Trust, London, UK.; Khushalani NI; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center, Tampa, Florida, USA.; Medina T; Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, USA.; Egger ME; Department of Medicine, University of Louisville, Louisville, Kentucky, USA.; Graf Finckenstein F; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Jagasia M; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Hari P; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Sulur G; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Shi W; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Wu X; Iovance Biotherapeutics Inc, San Carlos, California, USA.; Sarnaik A; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center, Tampa, Florida, USA amod.sarnaik@moffitt.org.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE